Ocuphire Pharma Inc. (OCUP) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
37000 GRAND RIVER AVE. FARMINGTON HILLS, MI 48335 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 50,516 | 42,683 | 24,753 | 16,399 | 12,200 | 8,744 | |||
| Cash and cash equivalents | 50,501 | 42,634 | 24,534 | 16,399 | 8,970 | 8,744 | |||
| Short-term investments | 15 | 49 | 219 | ||||||
| Other undisclosed cash, cash equivalents, and short-term investments | 3,230 | ||||||||
| Receivables | 926 | 1,298 | |||||||
| Prepaid expense | 997 | 1,373 | 1,243 | 1,243 | 618 | ||||
| Other current assets | 102 | 80 | 71 | 26 | 447 | 555 | |||
| Other undisclosed current assets | 1,407 | 3,552 | 17 | 5,982 | |||||
| Total current assets: | 53,948 | 48,986 | 26,067 | 17,668 | 12,664 | 15,900 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 6 | 10 | 14 | 76 | 112 | ||||
| Other undisclosed noncurrent assets | 229 | 31 | |||||||
| Total noncurrent assets: | 6 | 10 | 14 | 305 | 143 | ||||
| TOTAL ASSETS: | 53,948 | 48,992 | 26,077 | 17,682 | 12,969 | 16,043 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 3,968 | 2,753 | 3,317 | 3,185 | 1,266 | 3,153 | |||
| Accounts payable | 2,153 | 1,069 | 1,584 | 1,214 | |||||
| Accrued liabilities | 1,815 | 1,684 | 1,733 | 1,971 | |||||
| Other undisclosed accounts payable and accrued liabilities | 1,266 | 3,153 | |||||||
| Debt | 538 | ||||||||
| Derivative instruments and hedges, liabilities | 74 | ||||||||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 1,500 | |||
| Other undisclosed current liabilities | 140 | ||||||||
| Total current liabilities: | 4,042 | 2,753 | 3,855 | 3,185 | 2,905 | 3,153 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 20 | ||||||||
| Deferred rent credit | 20 | ||||||||
| Other undisclosed noncurrent liabilities | 27,964 | 105 | |||||||
| Total noncurrent liabilities: | 27,964 | 105 | 20 | ||||||
| Other undisclosed liabilities | 2,308 | ||||||||
| Total liabilities: | 4,042 | 2,753 | 3,855 | 31,149 | 3,011 | 5,480 | |||
| Equity | |||||||||
| Equity, attributable to parent | 49,906 | 46,239 | 22,222 | (13,467) | 9,958 | 10,563 | |||
| Common stock | 2 | 2 | 2 | 1 | 0 | 4 | |||
| Additional paid in capital | 131,370 | 117,717 | 111,588 | 19,207 | 173,278 | 165,264 | |||
| Accumulated other comprehensive income (loss) | 2 | (18) | |||||||
| Accumulated deficit | (81,466) | (71,480) | (89,368) | (32,675) | (163,323) | (154,687) | |||
| Total equity: | 49,906 | 46,239 | 22,222 | (13,467) | 9,958 | 10,563 | |||
| TOTAL LIABILITIES AND EQUITY: | 53,948 | 48,992 | 26,077 | 17,682 | 12,969 | 16,043 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 19,049 | 39,850 | 589 | 3,000 | ||||
| Gross profit: | 19,049 | 39,850 | 589 | 3,000 | ||||
| Operating expenses | (29,612) | (21,624) | (23,294) | (19,968) | (11,215) | (20,538) | ||
| Other undisclosed operating loss | (3,000) | |||||||
| Operating income (loss): | (10,563) | 18,226 | (22,705) | (19,968) | (11,215) | (20,538) | ||
| Nonoperating income (expense) | 1,917 | (14) | (33,986) | (1,477) | 2,580 | 6,169 | ||
| Investment income, nonoperating | 80 | (33,829) | (1,486) | 314 | 254 | |||
| Other nonoperating income (expense) | 1,837 | (14) | (157) | 9 | 369 | |||
| Interest and debt expense | (9) | (2) | (3,175) | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (8,646) | 18,203 | (56,693) | (24,620) | (8,635) | (14,369) | ||
| Other undisclosed loss from continuing operations before income taxes | (1,328) | |||||||
| Income (loss) from continuing operations before income taxes: | (9,974) | 18,203 | (56,693) | (24,620) | (8,635) | (14,369) | ||
| Income tax expense (benefit) | (12) | (315) | ||||||
| Income (loss) from continuing operations: | (9,986) | 17,888 | (56,693) | (24,620) | (8,635) | (14,369) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (56,693) | (24,620) | (8,635) | (14,369) | |
| Net income (loss) available to common stockholders, diluted: | (9,986) | 17,888 | (56,693) | (24,620) | (8,635) | (14,369) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (9,986) | 17,888 | (56,693) | (24,620) | (8,635) | (14,369) | ||
| Comprehensive income (loss): | (9,986) | 17,888 | (56,693) | (24,620) | (8,635) | (14,369) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 20 | 39 | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (9,986) | 17,888 | (56,693) | (24,620) | (8,616) | (14,329) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.